Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Proteomics study using Olink Reveal Kits

U.S. Department Of Health And Human Services·Maryland

Proteomics study using Olink Reveal Kits

Closes 6/26/2026$100k – $500kRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Center for Research on Genomics and Global Health (CRGGH) is seeking a proteomics study using Olink Reveal Kits. The CRGGH explores how genetic and environmental factors contribute to the onset of complex diseases like Type 2 diabetes, obesity, and hypertension. The researchers have gathered phenotypic data from more than 6,000 individuals and utilize various analytical methods, including genomics, transcriptomics, proteomics, and microbiomes. The goal is to conduct integrated analyses that unravel the underpinning mechanisms of these diseases. • The study aims to better understand the underlying causes of metabolic disorders. • The researchers have systematically collected diverse types of -omics data from participants. • The study will utilize Olink Reveal Kits for proteomics analysis. • The CRGGH has gathered data from over 6,000 individuals in the United States and internationally.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

James B. Law

[email protected]

Key dates

Opened
6/16/2026
Closes
6/26/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
325414
Solicitation №
75N98026Q00642

Budget estimate

$100,000 – $500,000

The budget for this opportunity is difficult to estimate as no specific payment amount is provided. However, considering the scope of the project, which involves a proteomics study using Olink Reveal Kits, the budget could be in the range of $100,000 to $500,000. This estimate is based on the assumption that the project will require significant resources, including personnel, equipment, and materials. Factors that may influence the likely payment range include the complexity of the study, the number of participants, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Energy·Ohio

Top match · 63%

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

U.S. Department Of Health And Human Services·Maryland

62% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. Department Of Defense·Virginia

61% match

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Closes 11/5/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

60% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

60% match

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Closes 10/8/2027Opened 11/21/2024

U.S. Department Of Health And Human Services·Maryland

60% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

60% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

60% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

Iowa State University·Iowa

59% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

59% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

59% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

59% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024

Colorado Department of Public Health and Environment·Colorado

59% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 9/30/2026

U.S. National Institutes of Health·United States of America

59% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. Department Of Energy·Ohio

59% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. Department Of Health And Human Services·Maryland

59% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

59% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

Mississippi State University·Mississippi

58% match

Sole Source Request to Purchase Alicat System Kits

Closes 11/12/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

58% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

Colorado Department of Public Health and Environment – Laboratory Services Division – Newborn Screening Program·Colorado

58% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

58% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

58% match

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

Closes 4/28/2027Opened 4/26/2024

U.S. Food and Drug Administration·United States of America

58% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. National Institutes of Health·United States of America

58% match

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 7/22/2021